secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIxCrypto Holdings, Inc. (AIXC)
CIK:        0001460702
Form:       8-K
Filed at:   2024-11-08T23:59:59+00:00
Accession:  0001493152-24-044346
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.03, 8.01, 5.03
LLM model:  deepseek-v4-flash:cloud@v2

Qualigen Therapeutics effects 1-for-50 reverse stock split to regain Nasdaq compliance
--------------------------------------------------------------------------------

- Reverse stock split at 1:50 ratio effective 12:01 a.m. ET on November 5, 2024.
- Reduces outstanding shares from ~36.8M to approx. 736k shares; no change in authorized shares.
- No fractional shares; cash in lieu paid at $5.055 per pre-split share (closing price on Nov 4).
- Intended to meet Nasdaq $1.00 minimum bid price requirement (Rule 5550(a)(2)).
- Trading symbol remains QLGN; CUSIP changed to 74754R 301.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1460702/000149315224044346/0001493152-24-044346-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1460702/000149315224044346/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-044346

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer